NewAmsterdam Pharma (NAMS) Current Leases (2022 - 2025)
Historic Current Leases for NewAmsterdam Pharma (NAMS) over the last 4 years, with Q3 2025 value amounting to $181000.0.
- NewAmsterdam Pharma's Current Leases fell 2458.33% to $181000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $181000.0, marking a year-over-year decrease of 2458.33%. This contributed to the annual value of $246000.0 for FY2024, which is 31000.0% up from last year.
- As of Q3 2025, NewAmsterdam Pharma's Current Leases stood at $181000.0, which was down 2458.33% from $225000.0 recorded in Q2 2025.
- NewAmsterdam Pharma's 5-year Current Leases high stood at $252000.0 for Q1 2025, and its period low was $43000.0 during Q1 2024.
- In the last 4 years, NewAmsterdam Pharma's Current Leases had a median value of $225000.0 in 2025 and averaged $171583.9.
- Examining YoY changes over the last 5 years, NewAmsterdam Pharma's Current Leases showed a top increase of 48604.65% in 2025 and a maximum decrease of 2458.33% in 2025.
- NewAmsterdam Pharma's Current Leases (Quarter) stood at $63255.3 in 2022, then dropped by 5.15% to $60000.0 in 2023, then skyrocketed by 310.0% to $246000.0 in 2024, then dropped by 26.42% to $181000.0 in 2025.
- Its Current Leases was $181000.0 in Q3 2025, compared to $225000.0 in Q2 2025 and $252000.0 in Q1 2025.